Royce & Associates’s Societal CDMO, Inc. Common Stock SCTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,293,382
Closed -$1.15M 935
2023
Q4
$1.15M Buy
3,293,382
+8,300
+0.3% +$3.03K 0.01% 729
2023
Q3
$1.54M Buy
3,285,082
+759,004
+30% +$542K 0.02% 679
2023
Q2
$2.78M Buy
2,526,078
+539,353
+27% +$475K 0.03% 620
2023
Q1
$2.36M Buy
1,986,725
+211,725
+12% +$278K 0.02% 630
2022
Q4
$2.64M Buy
+1,775,000
New +$2.79M 0.03% 601

Other funds holding SCTL

Royce & Associates's SCTL Position: Q1 2024 in Review

Royce & Associates sold out of Societal CDMO, Inc. Common Stock (SCTL) in Q1 2024, closing a stake of 3,293,382 shares — an estimated $1.15M sold.

Royce & Associates first reported a position in SCTL in Q4 2022 and held it in 5 quarters. The position peaked at $2.78M in Q2 2023. 46 funds tracked by Wall St. Rank hold SCTL as of Q1 2024.

  • Royce & Associates reported no remaining Societal CDMO, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Royce & Associates sold 3,293,382 Societal CDMO, Inc. Common Stock shares in Q1 2024, an estimated $1.15M.
  • Royce & Associates first reported a position in Societal CDMO, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Royce & Associates's Societal CDMO, Inc. Common Stock position peaked at $2.78M in Q2 2023.
  • 46 funds tracked by Wall St. Rank held Societal CDMO, Inc. Common Stock as of Q1 2024.

Based on Royce & Associates's 13F filing for Q1 2024, filed 13 May 2024.